The role of endocannabinoids in pain modulation. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3558695/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full – 2013) http/www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The endocannabinoid system, cannabinoids, and pain (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Therapeutic potential of cannabinoid medicines. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide (link to PDF – 2013) http/www.eurekaselect.com/107974/article
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF – 2013) http/www.eurekaselect.com/107975/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF – 2013) http/www.eurekaselect.com/108399/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial – 2013) http/virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454533
Anandamide deficiency and heightened neuropathic pain in aged mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23597506
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23742737
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23892011
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24117398
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24148808
Is Marijuana Medicinal? (news – 2013) http/www.rheumatologynews.com/index.php?id=8821&cHash=071010&tx_ttnews[tt_news]=127219
Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain (news – 2013) http/blog.norml.org/2013/01/03/study-vaporized-low-potency-cannabis-mitigates-neuropathic-pain/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Therapeutic benefits of cannabis: a patient survey. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2. (link to PDF – 2014) http/www.mdpi.com/1422-0067/15/8/13637
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24420962
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoidneurotrophin interactions. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24494680
Involvement of the endocannabinoid system in osteoarthritis pain. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24494687
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24703998
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24836296
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24906199
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/25058512
Cannabinoids for Neuropathic Pain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25160710
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25304184
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25393148
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25486617
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505113
Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients (news - 2014) http://blog.norml.org/2014/08/18/stu...athy-patients/
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015) http://www.jneuroinflammation.com/co...014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full – 2015) http://onlinelibrary.wiley.com/doi/1...pme.12569/full
Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst – 2015) http://onlinelibrary.wiley.com/doi/1...13012/abstract
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica. (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine. (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3558695/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full – 2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full – 2013) http/www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The endocannabinoid system, cannabinoids, and pain (full – 2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Therapeutic potential of cannabinoid medicines. (full – 2013) http/onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Non-Neuronal Cell Modulation Relieves Neuropathic Pain: Efficacy of the Endogenous Lipid Palmitoylethanolamide (link to PDF – 2013) http/www.eurekaselect.com/107974/article
Palmitoylethanolamide Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial Phenotypical Changes in Mice (link to PDF – 2013) http/www.eurekaselect.com/107975/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF – 2013) http/www.eurekaselect.com/108399/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial – 2013) http/virtualmentor.ama-assn.org/2013/05/oped1-1305.html
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23454533
Anandamide deficiency and heightened neuropathic pain in aged mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23597506
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23742737
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst – 2013) http/www.eurekaselect.com/106175/article
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/23892011
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24117398
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors. (abst – 2013) http/www.ncbi.nlm.nih.gov/pubmed/24148808
Is Marijuana Medicinal? (news – 2013) http/www.rheumatologynews.com/index.php?id=8821&cHash=071010&tx_ttnews[tt_news]=127219
Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain (news – 2013) http/blog.norml.org/2013/01/03/study-vaporized-low-potency-cannabis-mitigates-neuropathic-pain/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Therapeutic benefits of cannabis: a patient survey. (full – 2014) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2. (link to PDF – 2014) http/www.mdpi.com/1422-0067/15/8/13637
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24420962
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoidneurotrophin interactions. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24494680
Involvement of the endocannabinoid system in osteoarthritis pain. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24494687
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24703998
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24836296
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/24906199
(Mo1122) Prevalence and Characterization of Cannabinoid Use in Patients With Gastrointestinal Disorders (abst – 2014) http/www.gastrojournal.org/article/S0016-5085%2814%2962037-0/pdf
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models. (abst – 2014) http/www.ncbi.nlm.nih.gov/pubmed/25058512
Cannabinoids for Neuropathic Pain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25160710
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25118789
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25304184
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25393148
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25486617
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505113
Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients (news - 2014) http://blog.norml.org/2014/08/18/stu...athy-patients/
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015) http://www.jneuroinflammation.com/co...014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full – 2015) http://onlinelibrary.wiley.com/doi/1...pme.12569/full
Combined inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (abst – 2015) http://onlinelibrary.wiley.com/doi/1...13012/abstract
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955